Actively Recruiting
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
Led by Mohammad Daboos · Updated on 2024-07-23
21
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial study included 21 children with refractory benign esophageal strictures. Upper GI endoscopy performed up to the area of stricture, esophageal dilatation done, endoscopy repeated, and steroid injected intralesional under direct endoscopic vision. The effect of the procedure was followed over a period of 12 months by evaluation of number of dilatation, maximum dilator size, periodic dilatation index (PDI) and dysphagia score.
CONDITIONS
Official Title
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients aged less than 14 years
- Diagnosed with refractory benign esophageal strictures
- Have received dilation therapy without triamcinolone steroid injections
You will not qualify if you...
- Unable to pass a guide wire due to pharyngeal narrowing
- Presence of tracheo-esophageal fistula
- Received triamcinolone steroid injections during early dilation procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mohammad Daboos
Cairo, Select, Egypt, 115678
Actively Recruiting
Research Team
M
Mohammad Daboos
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here